GlassScriptPhysician profile
Clara L Tang
NPI 1275094252
$2,265.51
in general payments reported to CMS, 2019-2025
11 companies · $397 in 2025
The $397 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,869 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,512 · Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,511.97 |
| Food and Beverage | $753.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,564.40 | 2024 | |
| Meditrina | $204.87 | 2024-2025 | |
| Hologic Sales and Service, LLC | $175.79 | 2024-2025 | Acessa Provu System, Fluent Fluid Management System |
| Minerva Surgical, INC | $89.63 | 2025 | |
| Organon LLC | $72.05 | 2024 | |
| Sage Therapeutics, LLC | $55.20 | 2024-2025 | Zurzuvae |
| Axonics, INC. | $25.94 | 2024 | Bulkamid |
| Coopersurgical, INC. | $22.87 | 2025 | Paragard T 380a |
| Exeltis, USA INC. | $20.48 | 2025 | Slynd |
| Astellas Pharma US INC | $18.13 | 2025 | Veozah |
| Dexcom, INC. | $16.15 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.